Francesca Cancelli
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
Papers in
-
- COVID-19 Clinical Research Studies 11
- SARS-CoV-2 and COVID-19 Research 2
-
- Pneumonia and Respiratory Infections 3
- Co-authors
- Alessandra Oliva (18 shared papers)Claudio Maria Mastroianni (16 shared papers)Mario Venditti (9 shared papers)Massimiliano De Angelis (3 shared papers)Maria Teresa Mascellino (5 shared papers)Vincenzo Vullo (2 shared papers)Gianluca Russo (2 shared papers)Giancarlo Ceccarelli (3 shared papers)
- Journals
- Journal of Clinical Medicine (3 papers)Infection (2 papers)Journal of Antimicrobial Chemotherapy (2 papers)Antibiotics (1 paper)Frontiers in Microbiology (1 paper)
- Partner nations
- Italy
In The Last Decade
Francesca Cancelli
20 papers receiving 252 citations
Peers
Comparison fields: 5 of 62
- Applied Microbiology and Biotechnology 36
- Molecular Medicine 65
- Infectious Diseases 103
- Pharmacology 76
- Critical Care and Intensive Care Medicine 21
Countries citing papers authored by Francesca Cancelli
This map shows the geographic impact of Francesca Cancelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Cancelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Cancelli more than expected).
Fields of papers citing papers by Francesca Cancelli
This network shows the impact of papers produced by Francesca Cancelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Cancelli. The network helps show where Francesca Cancelli may publish in the future.
Co-authors
The 25 scholars most cited alongside Francesca Cancelli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 43 | |
| 2 | 2021 | 31 | |
| 3 | 2017 | 27 | |
| 4 | 2021 | 25 | |
| 5 | 2007 | 17 | |
| 6 | 2018 | 16 | |
| 7 | Efficacy of two micro-gravitational protocols to treat chronic low back pain associated with discal lesions: a randomized controlled trial. | 2004 | 15 |
| 8 | 2021 | 14 | |
| 9 | 2021 | 14 | |
| 10 | 2023 | 12 | |
| 11 | 2024 | 8 | |
| 12 | Convalescent plasma for haematological patients with SARS-CoV-2 pneumonia and severe depletion of B-cell lymphocytes following anti-CD20 therapy: a single-centre experience and review of the literature | 2022 | 7 |
| 13 | 2022 | 6 | |
| 14 | 2022 | 6 | |
| 15 | 2021 | 5 | |
| 16 | 2022 | 4 | |
| 17 | 2023 | 3 | |
| 18 | 2023 | 2 | |
| 19 | 2023 | 2 | |
| 20 | 2023 | 1 |
About Francesca Cancelli
Francesca Cancelli is a scholar working on Infectious Diseases, Epidemiology, Pharmacology, Molecular Medicine and Oncology, having authored 20 papers that have together received 258 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (11 papers), Antibiotic Resistance in Bacteria (6 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), COVID-19 and healthcare impacts (4 papers), Antibiotic Use and Resistance (4 papers), Pneumonia and Respiratory Infections (3 papers), Long-Term Effects of COVID-19 (2 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (36 citations), Molecular Medicine (65 citations), Infectious Diseases (103 citations), Pharmacology (76 citations) and Critical Care and Intensive Care Medicine (21 citations). Francesca Cancelli has collaborated with scholars based in Italy. Frequent co-authors include Alessandra Oliva, Claudio Maria Mastroianni, Mario Venditti, Massimiliano De Angelis, Maria Teresa Mascellino, Vincenzo Vullo, Gianluca Russo, Giancarlo Ceccarelli, Maria Claudia Miele and Vera Mauro. Their work appears in journals such as Journal of Clinical Medicine, Infection, Journal of Antimicrobial Chemotherapy, Antibiotics and Frontiers in Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.